There is an agreement in the field that interlaboratory reproducibility of flow cytometry measurements as well as the whole studies might be improved by a consensual use of methodological approach. Typically, a consensus is made on a crucial markers needed in the immunostaining panel, sometimes on the particular fluorochrome conjugates and rarely on a complete set of methods for sample preparation. The term "standardization" is used to describe the complete set of methodical steps, while "harmonization" is used for partial agreement on the method. Standardization can provide a platform for improved reproducibility of cytometry results over prolonged periods of time, across different sites and across different instruments. For the purpose of structured discussion, several desired aims are described: common interpretation of the immunophenotype definition of a target subset, accurate quantification, reproducible pattern of a multicolor immunophenotype, and reproducible intensity of all measured parameters. An overview of how standardization was approached by several large consortia is provided: EuroFlow, The ONE Study, Human Immunology Project Consortium (HIPC), and several other groups. Their particular aims and the tools adopted to reach those aims are noted. How those standardization efforts were adopted in the field and how the resulting outcome was evaluated is reviewed. Multiple challenges in the instrument hardware design, instrument setup tools, reagent design, and quality features need to be addressed to achieve optimal standardization. Furthermore, the aims of different studies vary, and thus, the reasonable requirements for standardization differ. A framework of reference for the reasonable outcomes of different approaches is offered. Finally, it is argued that complete standardization is important not only for the reproducibility of measurements but also for education, for quality assessment and for algorithmic data analysis. The different standardized approaches can and in fact should serve as benchmarking reference tools for the development of future flow cytometry studies. © 2019 International Society for Advancement of Cytometry.

CLIP Childhood Leukemia Investigation Prague Department of Pediatric Hematology and Oncology 2nd Medical School Charles University and University Hospital Motol Prague Czech Republic

Zobrazit více v PubMed

Kalina T, Flores-Montero J, Lecrevisse Q, Pedreira CE, van der Velden VHJ, Novakova M, Mejstrikova E, Hrusak O, Böttcher S, Karsch D, et al. Quality assessment program for EuroFlow protocols: Summary results of four-year (2010-2013) quality assurance rounds. Cytometry A 2015;87:145-156.

Maecker HT, McCoy JP, Amos M, Elliott J, Gaigalas A, Wang L, Aranda R, Banchereau J, Boshoff C, Braun J, et al. A model for harmonizing flow cytometry in clinical trials. Nat Immunol 2010;11:975-978.

Dworzak MN, Buldini B, Gaipa G, Ratei R, Hrusak O, Luria D, Rosenthal E, Bourquin J, Sartor M, Schumich A, et al. AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of pediatric acute lymphoblastic leukemia. Cytometry B Clin Cytom 2018;93:82-93.

Holzelova E, Vonarbourg C, Stolzenberg M-C, Arkwright PD, Selz F, Prieur A-M, Blanche S, Bartunkova J, Vilmer E, Fischer A, et al. Autoimmune lymphoproliferative syndrome with somatic Fas mutations. N Engl J Med 2004;351:1409-1418.

Stuchlý J, Kanderová V, Vlková M, Heřmanová I, Slámová L, Pelák O, Taraldsrud E, Jílek D, Králíčková P, Fevang B, et al. Common variable immunodeficiency patients with a phenotypic profile of immunosenescence present with thrombocytopenia. Sci Rep 2017;7:39710.

Davis BH, Wood B, Oldaker T, Barnett D. Validation of cell-based fluorescence assays: Practice guidelines from the ICSH and ICCS-part i-rationale and aims. Cytometry B Clin Cytom 2013;84:282-285.

Davis BH, Dasgupta A, Kussick S, Han JY, Estrellado A. Validation of cell-based fluorescence assays: Practice guidelines from the ICSH and ICCS-part II-Preanalytical issues. Cytometry B Clin Cytom 2013;84:286-290.

Tanqri S, Vall H, Kaplan D, Hoffman B, Purvis N, Porwit A, Hunsberger B, Shankey TV. Validation of cell-based fluorescence assays: Practice guidelines from the ICSH and ICCS-part III-analytical issues. Cytometry B Clin Cytom 2013;84:291-308.

Barnett D, Louzao R, Gambell P, De J, Oldaker T, Hanson CA. Validation of cell-based fluorescence assays: Practice guidelines from the ICSH and ICCS-part IV-postanalytic considerations. Cytometry B Clin Cytom 2013;84:309-314.

Wood B, Jevremovic D, Béné MC, Yan M, Jacobs P, Litwin V. Validation of cell-based fluorescence assays: Practice guidelines from the ICSH and ICCS-part V-assay performance criteria. Cytometry B Clin Cytom 2013;84:315-323.

Cossarizza A, Chang H-D, Radbruch A, Akdis M, Andrä I, Annunziato F, Bacher P, Barnaba V, Battistini L, Bauer WM, et al. Guidelines for the use of flow cytometry and cell sorting in immunological studies. Eur J Immunol 2017;47:1584-1797.

Kvistborg P, Gouttefangeas C, Aghaeepour N, Cazaly A, Chattopadhyay PK, Chan C, Eckl J, Finak G, Hadrup SR, Maecker HT, et al. Thinking outside the gate: Single-cell assessments in multiple dimensions. Immunity 2015;42:591-592.

Mcneil LK, Price L, Britten CM, Jaimes M, Maecker H, Odunsi K, Matsuzaki J, Staats JS, Thorpe J, Yuan J, et al. A harmonized approach to intracellular cytokine staining gating: Results from an international multiconsortia proficiency panel conducted by the Cancer Immunotherapy Consortium (CIC/CRI). Cytometry A 2013;83:728-738.

Finak G, Langweiler M, Jaimes M, Malek M, Taghiyar J, Korin Y, Raddassi K, Devine L, Obermoser G, Pekalski ML, et al. Standardizing flow cytometry immunophenotyping analysis from the Human ImmunoPhenotyping Consortium. Sci Rep 2016;6:20686.

Levering WHBM, Preijers FWMB, van Wieringen WN, Kraan J, van Beers WAM, Sintnicolaas K, van Rhenen DJ, Gratama JW. Flow cytometric CD34+ stem cell enumeration: Lessons from nine years' external quality assessment within the Benelux countries. Cytometry B Clin Cytom 2007;72:178-188.

Whitby A, Whitby L, Fletcher M, Reilly JT, Sutherland DR, Keeney M, Barnett D. ISHAGE protocol: Are we doing it correctly? Cytometry B Clin Cytom 2012;82B:9-17.

Lacombe F, Bernal E, Bloxham D, Couzens S, Porta MGD, Johansson U, Kern W, Macey M, Matthes T, Morilla R, et al. Harmonemia: a universal strategy for flow cytometry immunophenotyping-A European LeukemiaNet WP10 study. Leukemia 2016;30:1762-1772.

Hrušák O, Basso G, Ratei R, Gaipa G, Luria D, Mejstříková E, Karawajew L, Buldini B, Rozenthal E, Bourquin JP, et al. Flow diagnostics essential code: a simple and brief format for the summary of leukemia phenotyping. Cytometry B Clin Cytom 2014;86:288-291.

Dworzak MN, Gaipa G, Ratei R, Veltroni M, Schumich A, Maglia O, Karawajew L, Benetello A, Pötschger U, Husak Z, et al. Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasible. Cytometry B Clin Cytom 2008;74:331-340.

Karawajew L, Dworzak M, Ratei R, Rhein P, Gaipa G, Buldini B, Basso G, Hrusak O, Ludwig W-D, Henze G, et al. Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia. Haematologica 2015;100:935-944.

Rawstron A, Böttcher S, Letestu R, Villamor N, Fazi C, Kartsios H, de Tute RM, Shingles J, Ritgen M, Moreno C, et al. Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL. Leukemia 2013;27:142-149.

Rawstron AC, Fazi C, Agathangelidis A, Villamor N, Letestu R, Nomdedeu J, Palacio C, Stehlikova O, Kreuzer K-A, Liptrot S, et al. A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: An European Research Initiative on CLL study. Leukemia 2016;30:929-936.

Rawstron AC, Villamor N, Ritgen M, Böttcher S, Ghia P, Zehnder JL, Lozanski G, Colomer D, Moreno C, Geuna M, et al. International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia. Leukemia 2007;21:956-964.

Schlickeiser S, Streitz M, Sawitzki B. Standardized multi-color flow cytometry and computational biomarker discovery. Methods Mol Biol 2016;1371:225-238.

Streitz M, Miloud T, Kapinsky M, Reed MR, Magari R, Geissler EK, Hutchinson JA, Vogt K, Schlickeiser S, Kverneland A, et al. Standardization of whole blood immune phenotype monitoring for clinical trials: Panels and methods from the ONE study. Transplant Res 2013;2:17.

Maecker HT, McCoy JP, Nussenblatt R. Standardizing immunophenotyping for the human immunology project. Nat Rev Immunol 2012;12:191-200.

Courtot M, Meskas J, Diehl AD, Droumeva R, Gottardo R, Jalali A, Taghiyar MJ, Maecker HT, McCoy JP, Ruttenberg A, et al. flowCL: Ontology-based cell population labelling in flow cytometry. Bioinformatics 2015;31:1337-1339.

Flores-Montero J, Sanoja-Flores L, Paiva B, Puig N, García-Sánchez O, Böttcher S, van der Velden VHJ, Pérez-Morán J-J, Vidriales M-B, García-Sanz R, et al. Next generation flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma. Leukemia 2017;31:2094-2103.

van Dongen JJM, van der Velden VHJ, Brüggemann M, Orfao A. Minimal residual disease diagnostics in acute lymphoblastic leukemia: Need for sensitive, fast, and standardized technologies. Blood 2015;125:3996-4009.

Theunissen P, Mejstrikova E, Sedek L, van der Sluijs-Gelling AJ, Gaipa G, Bartels M, Sobral da Costa E, Kotrova M, Novakova M, Sonneveld E, et al. Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia. Blood 2017;129:347-357.

Borowitz MJ, Wood BL, Devidas M, Loh ML, Raetz EA, Salzer WL, Nachman JB, Carroll AJ, Heerema NA, Gastier-Foster JM, et al. Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232. Blood 2015;126:964-971.

van Dongen JJM, van der Burg M, Kalina T, Perez-Andres M, Mejstrikova E, Vlkova M, Lopez-Granados E, Wentink M, Kienzler A-K, Philippé J, et al. EuroFlow-based flowcytometric diagnostic screening and classification of primary immunodeficiencies of the lymphoid system. Front Immunol 2019;10:1-21.

van Dongen JJM, Lhermitte L, Böttcher S, Almeida J, van der Velden VHJ, Flores-Montero J, Rawstron A, Asnafi V, Lécrevisse Q, Lucio P, et al. EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia 2012;26:1908-1975.

Lhermitte L, Mejstrikova E, Van Der Sluijs-Gelling AJ, Grigore GE, Sedek L, Bras AE, Gaipa G, Sobral Da Costa E, Novakova M, Sonneveld E, et al. Automated database-guided expert-supervised orientation for immunophenotypic diagnosis and classification of acute leukemia. Leukemia 2018;32:874-881.

Ivison S, Malek M, Garcia RV, Broady R, Halpin A, Richaud M, Brant RF, Wang S-I, Goupil M, Guan Q, et al. A standardized immune phenotyping and automated data analysis platform for multicenter biomarker studies. JCI Insight 2018;3:e121867.

van Dongen JJM, Orfao A. EuroFlow: Resetting leukemia and lymphoma immunophenotyping. Basis for companion diagnostics and personalized medicine. Leukemia 2012;26:1899-1907.

Kalina T, Flores-Montero J, van der Velden VHJ, Martin-Ayuso M, Böttcher S, Ritgen M, Almeida J, Lhermitte L, Asnafi V, Mendonça A, et al. EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols. Leukemia 2012;26:1986-2010.

Theunissen P, Mejstrikova E, Sedek L, Van Der Sluijs-Gelling AJ, Gaipa G, Bartels M, Sobral da Costa E, Kotrová M, Novakova M, Sonneveld E, et al. Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia. Blood 2017;129:347-357.

Pedreira CE, Costa ES, Arroyo ME, Almeida J, Orfao A. A multidimensional classification approach for the automated analysis of flow cytometry data. IEEE Trans Biomed Eng 2008;55:1155-1162.

Glier H, Heijnen I, Hauwel M, Dirks J, Quarroz S, Lehmann T, Rovo A, Arn K, Matthes T, Hogan C, et al. Standardization of 8-color flow cytometry across different flow cytometer instruments: A feasibility study in clinical laboratories in Switzerland. J Immunol Methods 2017. https://doi.org/10.1016/j.jim.2017.07.013.

Nováková M, Glier H, Brdičková N, Vlková M, Santos AH, Lima M, Roussel M, Flores-Montero J, Szczepanski T, Böttcher S, et al. How to make usage of the standardized EuroFlow 8-color protocols possible for instruments of different manufacturers. J Immunol Methods 2017. https://doi.org/10.1016/j.jim.2017.11.007.

Preijers FWMB, Huys E, Favre C, Moshaver B. Establishment of harmonization in immunophenotyping: A comparative study of a standardized one-tube lymphocyte-screening panel. Cytometry B Clin Cytom 2014;86:418-425.

Solly F, Rigollet L, Baseggio L, Guy J, Borgeot J, Guérin E, Debliquis A, Drenou B, Campos L, Lacombe F, et al. Comparable flow cytometry data can be obtained with two types of instruments, canto II, and navios. A GEIL study. Cytometry A 2013;83:1066-1072.

Borowitz MJ, Devidas M, Hunger SP, Bowman WP, Carroll AJ, Carroll WL, Linda S, Martin PL, Pullen DJ, Viswanatha D, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors : A Children's Oncology Group study. Blood 2008;111:5477-5485.

Keeney M, Wood BL, Hedley BD, DiGiuseppe JA, Stetler-Stevenson M, Paietta E, Lozanski G, Seegmiller AC, Greig BW, Shaver AC, et al. A QA program for MRD testing demonstrates that systematic education can reduce discordance among experienced interpreters. Cytometry B Clin Cytom 2018;94:239-249.

Appay V, van Lier RAW, Sallusto F, Roederer M. Phenotype and function of human T lymphocyte subsets: Consensus and issues. Cytometry A 2008;73:975-983.

Mahnke YD, Brodie TM, Sallusto F, Roederer M, Lugli E. The who's who of T-cell differentiation: Human memory T-cell subsets. Eur J Immunol 2013;43:2797-2809.

Brusic V, Gottardo R, Kleinstein SH, Davis MM, Committee H steering, Davis MM, Hafler DA, Quill H, Palucka AK, Poland GA, et al. Computational resources for high-dimensional immune analysis from the human immunology project consortium. Nat Biotechnol 2014;32:146-148.

Kverneland AH, Streitz M, Geissler E, Hutchinson J, Vogt K, Bo??s D, Niemann N, Pedersen AE, Schlickeiser S, Sawitzki B. Age and gender leucocytes variances and references values generated using the standardized ONE-study protocol. Cytometry A 2016;89:543-564.

Jamin C, Le Lann L, Alvarez-Errico D, Barbarroja N, Cantaert T, Ducreux J, Dufour AM, Gerl V, Kniesch K, Neves E, et al. Multi-center harmonization of flow cytometers in the context of the European “PRECISESADS” project. Autoimmun Rev 2016;15:1038-1045.

van der Velden VHJ, Flores-Montero J, Perez-Andres M, Martin-Ayuso M, Crespo O, Blanco E, Kalina T, Philippé J, Bonroy C, de Bie M, et al. Optimization and testing of dried antibody tube: The EuroFlow LST and PIDOT tubes as examples. J Immunol Methods 2017. https://doi.org/10.1016/j.jim.2017.03.011.

van der Burg M, Kalina T, Perez-Andres M, Vlkova M, Lopez-Granados E, Blanco E, Bonroy C, Sousa AE, Kienzler A-K, Wentink M, et al. The EuroFlow PID orientation tube for flow cytometric diagnostic screening of primary immunodeficiencies of the lymphoid system. Front Immunol 2019;10:246.

Blanco E, Pérez-Andrés M, Arriba-Méndez S, Contreras-Sanfeliciano T, Criado I, Pelak O, Serra-Caetano A, Romero A, Puig N, Remesal A, et al. Age-associated distribution of normal B-cell and plasma cell subsets in peripheral blood. J Allergy Clin Immunol 2018;141:2208-2219.e16.

Blanco E, Perez-Andres M, Sanoja-Flores L, Wentink M, Pelak O, Martín-Ayuso M, Grigore G, Torres-Canizales J, López-Granados E, Kalina T, et al. Selection and validation of antibody clones against IgG and IgA subclasses in switched memory B-cells and plasma cells. J Immunol Methods 2017. https://doi.org/10.1016/j.jim.2017.09.008.

Blanco E, Pérez-Andrés M, Arriba-Méndez S, Serrano C, Criado I, Del Pino-Molina L, Silva S, Madruga I, Bakardjieva M, Martins C, et al. EuroFlow PID group. Defects in memory B-cell and plasma cell subsets expressing different immunoglobulin-subclasses in CVID and Ig-subclass deficiencies. J Allergy Clin Immunol 2019;144:809-824.

Menditto A, Patriarca M, Magnusson B. Understanding the meaning of accuracy, trueness and precision. Accredit Qual Assur 2007;12:45-47.

Bainbridge J, Rountree W, Louzao R, Wong J, Whitby L, Denny TN, Barnett D. Laboratory accuracy improvement in the UKNEQAS leucocyte Immunophenotyping immune monitoring program: An eleven-year review via longitudinal mixed effects modeling. Cytometry B Clin Cytom 2018;94:250-256.

Reilly JT, Barnett D. UKNEQAS for leucocyte immunophenotyping: The first 10 years. J Clin Pathol 2001;54:508-511.

Preijers FWMB, Van Der Velden VHJ, Preijers T, Brooimans RA, Marijt E, Homburg C, Van Montfort K, Gratama JW. Fifteen years of external quality assessment in leukemia/lymphoma immunophenotyping in The Netherlands and Belgium: A way forward. Cytometry B Clin Cytom 2016;90:267-278.

Barnett D, Granger V, Kraan J, Whitby L, Reilly JT, Papa S, Gratama JW. Reduction of intra- and interlaboratory variation in CD34+ stem cell enumeration using stable test material, standard protocols and targeted training. DK34 Task Force of the European Working Group of Clinical Cell Analysis (EWGCCA). Br J Haematol 2000;108:784-792.

Barnett D, Granger V, Whitby L, Storie I, Reilly JT. Absolute CD4+ T-lymphocyte and CD34+ stem cell counts by single-platform flow cytometry: The way forward. Br J Haematol 1999;106:1059-1062.

Whitby L, Granger V, Storie I, Goodfellow K, Sawle A, Reilly JT, Barnett D. Quality control of CD4+ T-lymphocyte enumeration: Results from the last 9 years of the United Kingdom National External Quality Assessment Scheme for immune monitoring (1993-2001). Cytometry 2002;50:102-110.

Ticchioni M, Brouzes C, Durrieu F, Lambert C. Acceptable “real-life” variability for lymphocyte counts by flow cytometry. Cytometry B Clin Cytom 2019;96B:379-388.

Roederer M. How many events is enough? Are you positive? Cytometry A 2008;73A:384-385.

Kalina T, Brdickova N, Glier H, Fernandez P, Bitter M, Flores-Montero J, van Dongen JJM, Orfao A. Frequent issues and lessons learned from EuroFlow QA. J Immunol Methods 2018. https://doi.org/10.1016/j.jim.2018.09.008.

Parks DR, Moore WA, Brinkman RR, Chen Y, Condello D, El Khettabi F, Nolan JP, Perfetto SP, Redelman D, Spidlen J, et al. Methodology for evaluating and comparing flow cytometers: A multisite study of 23 instruments. Cytometry A 2018;93:1087-1091.

Hulspas R, Dombkowski D, Preffer F, Douglas D, Kildew-Shah B, Gilbert J. Flow cytometry and the stability of phycoerythrin-tandem dye conjugates. Cytometry A 2009;75:966-972.

Zarkowsky D, Lamoreaux L, Chattopadhyay P, Koup RA, Perfetto SP, Roederer M. Heavy metal contaminants can eliminate quantum dot fluorescence. Cytometry A 2011;79:84-89.

Nomura L, Maino VC, Maecker HT. Standardization and optimization of multiparameter intracellular cytokine staining. Cytometry A 2008;73A:984-991.

Wood BL, Arroz M, Barnett D, DiGiuseppe J, Greig B, Kussick SJ, Oldaker T, Shenkin M, Stone E, Wallace P. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: Optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia. Cytometry B Clin Cytom 2007;72(Suppl 1):S14-S22.

Roederer M, Tárnok A. OMIPs-Orchestrating multiplexity in polychromatic science. Cytometry A 2010;77:811-812.

Mair F, Prlic M. OMIP-044: 28-color immunophenotyping of the human dendritic cell compartment. Cytometry A 2018;93:402-405.

Staser KW, Eades W, Choi J, Karpova D, DiPersio JF. OMIP-042: 21-color flow cytometry to comprehensively immunophenotype major lymphocyte and myeloid subsets in human peripheral blood. Cytometry A 2018;93:186-189.

Baumgart S, Peddinghaus A, Schulte-Wrede U, Mei HE, Grützkau A. OMIP-034: Comprehensive immune phenotyping of human peripheral leukocytes by mass cytometry for monitoring immunomodulatory therapies. Cytometry A 2016;91:34-38.

Engel P, Boumsell L, Balderas R, Bensussan A, Gattei V, Horejsi V, Jin B-Q, Malavasi F, Mortari F, Schwartz-Albiez R, et al. CD nomenclature 2015: Human leukocyte differentiation antigen workshops as a driving force in immunology. J Immunol 2015;195:4555-4563.

Mahnke YD, Roederer M. Optimizing a multicolor immunophenotyping assay. Clin Lab Med 2007;27:469-485.

Davis KA, Abrams B, Iyer SB, Hoffman RA, Bishop JE. Determination of CD4 antigen density on cells: Role of antibody valency, avidity, clones, and conjugation. Cytometry 1998;33:197-205.

Wang L, Abbasi F, Ornatsky O, Cole KD, Misakian M, Gaigalas AK, He HJ, Marti GE, Tanner S, Stebbings R. Human CD4+ lymphocytes for antigen quantification: Characterization using conventional flow cytometry and mass cytometry. Cytometry A 2012;81 A:567-575.

Kalina T, Lundsten K, Engel P. Relevance of antibody validation for flow cytometry. Cytometry A 2019; in press.

Maecker HT, Frey T, Nomura LE, Trotter J. Selecting fluorochrome conjugates for maximum sensitivity. Cytometry A 2004;62:169-173.

Böttcher S, van der Velden V, Villamor N, Ritgen M, Flores-Montero J, Escobar HM, Kalina T, Brüggemann M, Grigore G, Martin-Ayuso M, et al. Lot-to-lot stability of antibody reagents for flow cytometry. J Immunol Methods 2017. https://doi.org/10.1016/j.jim.2017.03.018.

Hedley BD, Keeney M, Popma J, Chin-Yee I. Novel lymphocyte screening tube using dried monoclonal antibody reagents. Cytometry B Clin Cytom 2015;88:361-370.

Lee JA, Spidlen J, Boyce K, Cai J, Crosbie N, Dalphin M, Furlong J, Gasparetto M, Goldberg M, Goralczyk EM, et al. International Society for Advancement of Cytometry Data Standards Task Force, Scheuermann RH, Brinkman RR. MIFlowCyt: The minimum information about a flow cytometry experiment. Cytometry A 2008;73:926-930.

Schulz AR, Baumgart S, Schulze J, Urbicht M, Grützkau A, Mei HE. Stabilizing antibody cocktails for mass cytometry. Cytometry A 2019;95:910-916.

Li SKH, Majonis D, Bagwell CB, Hunsberger BC, Baranov V, Ornatsky O. An efficient human whole blood workflow using CyTOF technology: a lyophilized 30-plex antibody panel coupled with automated data analysis. J Immunol 2018;200:120.2 LP-120.2.

Cosma A. Universal cell type identifier based on number theory. Cytometry A 2018;93:649-652.

Diggins KE, Greenplate AR, Leelatian N, Wogsland CE, Irish JM. Characterizing cell subsets using marker enrichment modeling. Nat Methods 2017;14:275-278.

Diggins KE, Gandelman JS, Roe CE, Irish JM. Generating quantitative cell identity labels with marker enrichment modeling (MEM). Curr Protoc Cytom 2018;83:10.21.1-10.21.28.

Enhancing reproducibility in single cell research with biocytometry: An inter-laboratory study

Standardization of Workflow and Flow Cytometry Panels for Quantitative Expression Profiling of Surface Antigens on Blood Leukocyte Subsets: An HCDM CDMaps Initiative

Expert-independent classification of mature B-cell neoplasms using standardized flow cytometry: a multicentric study

Editorial: Application of Cytometry in Primary Immunodeficiencies